The Stock Exchange of Hong Kong Limited (HKEX) announced on July 24, 2026, the immediate implementation of new Listing Rules aimed at enhancing the competitiveness of Hong Kong's listing framework. These changes are the result of a consultation paper and received strong support from respondents, with many noting that the relaxed thresholds would bring Hong Kong more in line with other markets that have tailored WVR requirements. HKEX hopes these reforms will attract more innovative companies, particularly those from Greater China that have previously opted to list with WVR structures on US exchanges.
Key amendments include a significant reduction in the financial eligibility thresholds for companies with Weighted Voting Rights (WVR). WVR Test A's expected market capitalization threshold has been lowered from HK$40 billion to at least HK$20 billion ($2.22 billion). WVR Test B's expected market capitalization threshold has been reduced from HK$10 billion to at least HK$6 billion ($765 million), and its revenue requirement for the most recent audited financial year has been lowered from HK$1 billion to at least HK$600 million ($76.5 million). These lowered thresholds apply to both primary WVR listings and secondary listings for overseas issuers with WVR structures.
In addition to the financial eligibility changes, HKEX has streamlined other listing requirements. Confidential filing is now available to all new listing applicants, allowing them to delay publishing their Application Proof. The rules also offer greater flexibility regarding changes in controlling shareholders, provided there is no material change in management influence. Furthermore, Biotech and Specialist Technology Companies can now seek listing under specialist chapters even if they meet general eligibility tests. HKEX's Head of Listing, Katherine Ng, stated that these reforms are a major step in enhancing the flexibility and diversity of Hong Kong's listing regime.
